RxDoctor Payments Data

Shannon Ellis, MD

Family Medicine · Hoschton, GANPI 1124219563

Payments from drug & device makers

$2,549in general payments, 2019–2025

Across 120 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Theratechnologies Inc.$452
  • Novartis$419
  • Novo Nordisk$364
  • Abbott$261
  • Janssen Products, LP$200
  • Lilly USA, LLC$175
  • plus $678 from 11 others

What the payments were for

  • Food & beverage$2,21987%
  • Education$33013%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,549 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$142,660
Medicare patients
278
Services billed
2,679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide123$145,793
JardianceEmpagliflozin61$82,852
MounjaroTirzepatide37$48,327
JanuviaSitagliptin Phosphate30$44,462
TrulicityDulaglutide14$33,410
FarxigaDapagliflozin Propanediol31$31,296
ArexvyRsvpref3 Antigen/As01e/Pf84$26,012
Spiriva HandihalerTiotropium Bromide28$19,321
EliquisApixaban15$18,784
XareltoRivaroxaban17$17,462
Tresiba Flextouch U-100Insulin Degludec20$15,464
Breo ElliptaFluticasone/Vilanterol26$10,447
ShingrixVaricella-Zoster Ge/As01b/Pf34$7,597
SymbicortBudesonide/Formoterol Fumarate23$7,038
Atorvastatin Calcium608$5,736

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$364$145,793123 claims
Lilly USA, LLCMounjaro, Trulicity$175$81,73851 claims
GSKArexvy, Breo Ellipta, Shingrix$77$44,056144 claims
PfizerEliquis, Premarin$173$22,01331 claims
AbbVieSynthroid$137$3,56535 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Hoschton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →